ArticleOncology letters2017

Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.

Yosuke Miura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.